| 1 |
33627632 | Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane. | 2021 Feb 24 |
1 |
| 2 |
33952826 | Rapid Increase of Gastrointestinal P-Glycoprotein Functional Activity in Response to Etoposide Stimulation. | 2021 |
7 |
| 3 |
30650062 | MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer. | 2019 Mar |
3 |
| 4 |
30977678 | ABCB1 (C1236T) Polymorphism Affects P-Glycoprotein-Mediated Transport of Methotrexate, Doxorubicin, Actinomycin D, and Etoposide. | 2019 May |
8 |
| 5 |
31311995 | A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma. | 2019 Jul 16 |
1 |
| 6 |
27926506 | Disruption of the association between drug transporter and actin cytoskeleton abolishes drug resistance in hypertrophic scar. | 2017 Jan 10 |
1 |
| 7 |
28070169 | Overexpression of trefoil factor 3 (TFF3) contributes to the malignant progression in cervical cancer cells. | 2017 |
2 |
| 8 |
28291743 | Lactobionic acid-conjugated TPGS nanoparticles for enhancing therapeutic efficacy of etoposide against hepatocellular carcinoma. | 2017 May 12 |
1 |
| 9 |
28587395 | Effectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells in vitro. | 2017 Jun |
1 |
| 10 |
26548759 | Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. | 2016 |
1 |
| 11 |
26827764 | ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth. | 2016 Apr |
1 |
| 12 |
27570640 | Transient resistance to DNA damaging agents is associated with expression of microRNAs-135b and -196b in human leukemia cell lines. | 2016 |
1 |
| 13 |
27840903 | Low dose of arsenic trioxide inhibits multidrug resistant-related P-glycoprotein expression in human neuroblastoma cell line. | 2016 Dec |
1 |
| 14 |
32263493 | Overcoming multidrug resistance by a combination of chemotherapy and photothermal therapy mediated by carbon nanohorns. | 2016 Sep 28 |
2 |
| 15 |
25395162 | Upregulation of Stat1-HDAC4 confers resistance to etoposide through enhanced multidrug resistance 1 expression in human A549 lung cancer cells. | 2015 Mar |
1 |
| 16 |
25866761 | Thyroid hormone and P-glycoprotein in tumor cells. | 2015 |
1 |
| 17 |
25901027 | Circadian modulation in the intestinal absorption of P-glycoprotein substrates in monkeys. | 2015 Jul |
2 |
| 18 |
25948303 | [Role of Scaffold Proteins in Functional Alteration of Small Intestinal P-glycoprotein by Anti-cancer Drugs]. | 2015 |
5 |
| 19 |
26136652 | Inhibition of multidrug resistance protein 1 (MRP1) improves chemotherapy drug response in primary and recurrent glioblastoma multiforme. | 2015 |
3 |
| 20 |
26153782 | P-glycoprotein is expressed and causes resistance to chemotherapy in EBV-positive T-cell lymphoproliferative diseases. | 2015 Oct |
1 |
| 21 |
26463638 | Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60). | 2015 Oct |
4 |
| 22 |
26515462 | Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity. | 2015 Nov 10 |
2 |
| 23 |
24220725 | Extract of Bryophyllum laetivirens reverses etoposide resistance in human lung A549 cancer cells by downregulation of NF-κB. | 2014 Jan |
1 |
| 24 |
24868599 | FTY720 enhances chemosensitivity of colon cancer cells to doxorubicin and etoposide via the modulation of P-glycoprotein and multidrug resistance protein 1. | 2014 May |
2 |
| 25 |
24882643 | [Effect of repeated oral treatment with etoposide on the expression of intestinal P-glycoprotein and oral morphine analgesia]. | 2014 |
6 |
| 26 |
24887326 | Overcoming multiple drug resistance mechanisms in medulloblastoma. | 2014 May 30 |
2 |
| 27 |
24989004 | Changes in PtdIns(4,5)P2 induced by etoposide treatment modulates small intestinal P-glycoprotein via radixin. | 2014 |
6 |
| 28 |
25087953 | Schedule-dependent cytotoxicity of Etoposide and cyclophosphamide in P-glycoprotein-expressing human leukemic K-562 cells. | 2014 |
1 |
| 29 |
23254912 | Effects of morin on the pharmacokinetics of etoposide in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in female Sprague-Dawley rats. | 2013 Mar |
2 |
| 30 |
23303573 | Activation of ERM-family proteins via RhoA-ROCK signaling increases intestinal P-gp expression and leads to attenuation of oral morphine analgesia. | 2013 Mar |
5 |
| 31 |
23508810 | Time-dependent changes in the activation of RhoA/ROCK and ERM/p-ERM in the increased expression of intestinal P-glycoprotein by repeated oral treatment with etoposide. | 2013 May |
6 |
| 32 |
23909136 | Self-nanoemulsifying lipid carrier system for enhancement of oral bioavailability of etoposide by P-glycoprotein modulation: in vitro cell line and in vivo pharmacokinetic investigation. | 2013 Jul |
3 |
| 33 |
23981337 | Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition. | 2013 Nov 20 |
5 |
| 34 |
24189426 | Radixin influences the changes in the small intestinal P-glycoprotein by etoposide treatment. | 2013 |
7 |
| 35 |
22116711 | A new anticancer compound, oblongifolin C, inhibits tumor growth and promotes apoptosis in HeLa cells through Bax activation. | 2012 Sep 15 |
1 |
| 36 |
22420656 | Etoposide modulates the effects of oral morphine analgesia by targeting the intestinal P-glycoprotein. | 2012 Apr |
7 |
| 37 |
22543673 | Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy. | 2012 Sep |
1 |
| 38 |
22982667 | RhoA affects oral morphine analgesia depending on functional variation in intestinal P-glycoprotein induced by repeated etoposide treatment. | 2012 Dec 18 |
9 |
| 39 |
20856196 | Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. | 2011 Jan 27 |
1 |
| 40 |
21356302 | Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption. | 2011 May 16 |
2 |
| 41 |
21498714 | Overcoming multidrug resistance in human lung cancer with novel benzo[a]quinolizin-4-ones. | 2011 Mar |
2 |
| 42 |
21514380 | Suppression of multidrug resistance by treatment with TRAIL in human ovarian and breast cancer cells with high level of c-Myc. | 2011 Jul |
1 |
| 43 |
19817749 | Increased chemoresistance induced by inhibition of HIF-prolyl-hydroxylase domain enzymes. | 2010 Jan |
1 |
| 44 |
20309692 | MDR1 C2005T polymorphism changes substrate specificity. | 2010 Aug |
1 |
| 45 |
19723047 | Inhibition of P-glycoprotein by wogonin is involved with the potentiation of etoposide-induced apoptosis in cancer cells. | 2009 Aug |
1 |
| 46 |
19725578 | Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives. | 2009 Sep 10 |
2 |
| 47 |
18282684 | Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line. | 2008 Jun |
2 |
| 48 |
18723777 | A novel human multidrug resistance gene MDR1 variant G571A (G191R) modulates cancer drug resistance and efflux transport. | 2008 Nov |
1 |
| 49 |
17279585 | Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. | 2007 Mar 1 |
1 |
| 50 |
17351391 | Correlations between the activities of 19 standard anticancer agents, antioxidative enzyme activities and the expression of ATP-binding cassette transporters: comparison with the National Cancer Institute data. | 2007 Apr |
1 |